Yinxia Chen

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Wanhong Zhao, Jie Liu, Baiyan Wang et al. · Journal of Hematology & Oncology · 2018 · 536 citations · Full text

Medicine, Hematology, Immunology +16

Tribological Properties of CaCO3 Nanoparticles as an Additive in Lithium Grease

Xianbing Ji, Yinxia Chen, Gaiqing Zhao et al. · Tribology Letters · 2010 · 165 citations

Natural Sciences, Materials Engineering, Materials Science +16

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Wanhong Zhao, Baiyan Wang, Lijuan Chen et al. · Journal of Hematology & Oncology · 2022 · 142 citations · Full text

Medicine, Hematology, Pharmacology +14

Effects of oxidative modification on textural properties and gel structure of pork myofibrillar proteins

Minquan Xia, Yinxia Chen, Juanjuan Guo et al. · Food Research International · 2018 · 129 citations

Agriculture, Biochemistry, Food Science +17

Management of cytokine release syndrome related to CAR-T cell therapy

Hongli Chen, Fangxia Wang, Pengyu Zhang et al. · Frontiers of Medicine · 2019 · 106 citations

Life Sciences, Immunology, Immunoregulation +13